Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All metformin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchMetforminMetformin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review

Plowman et al., International Journal of Molecular Sciences, doi:10.3390/ijms25105190
May 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Metformin for COVID-19
3rd treatment shown to reduce risk in July 2020, now with p < 0.00000000001 from 97 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 109 treatments. c19early.org
Review of the potential of metformin for preventing inflammatory complications and infectious diseases including COVID-19. Authors discuss evidence from preclinical and clinical studies suggesting metformin may help prevent symptoms of COVID-19 when used alone or as an adjuvant with other antiviral medications. Metformin has been shown to phosphorylate the ACE2 receptor and change its conformation, potentially blocking SARS-CoV-2 binding. It may also control the COVID-19-induced cytokine storm by preventing NF-κB-induced inflammatory response and NLRP3-induced innate immune response in an AMPK-dependent manner. Additionally, by activating endosomal ATPases, metformin could interfere with viral maturation and assembly. Metformin's ability to increase insulin sensitivity and endothelial function may help protect against COVID-19 cardiopulmonary effects.
Reviews covering metformin for COVID-19 include1-7.
Plowman et al., 10 May 2024, multiple countries, peer-reviewed, 6 authors. Contact: karamana@noordacom.org (corresponding author).
This PaperMetforminAll
Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
Trevor J Plowman, Hannah Christensen, Myia Aiges, Emely Fernandez, Mujtaba H Shah, Kota V Ramana
International Journal of Molecular Sciences, doi:10.3390/ijms25105190
Metformin, a widely used first-line anti-diabetic therapy for the treatment of type-2 diabetes, has been shown to lower hyperglycemia levels in the blood by enhancing insulin actions. For several decades this drug has been used globally to successfully control hyperglycemia. Lactic acidosis has been shown to be a major adverse effect of metformin in some type-2 diabetic patients, but several studies suggest that it is a typically well-tolerated and safe drug in most patients. Further, recent studies also indicate its potential to reduce the symptoms associated with various inflammatory complications and infectious diseases including coronavirus disease 2019 . These studies suggest that besides diabetes, metformin could be used as an adjuvant drug to control inflammatory and infectious diseases. In this article, we discuss the current understanding of the role of the antidiabetic drug metformin in the prevention of various inflammatory complications and infectious diseases in both diabetics and non-diabetics.
Author Contributions: T.J.P., H.C., M.A., E.F. and M.H.S. drafted the initial manuscript and reviewed and edited the final draft. K.V.R. conceptualized, drafted, reviewed, and edited the manuscript. All authors have read and agreed to the published version of the manuscript.
References
Abbas, Elsherbini, Shaldam, Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa, Afr. Health Sci, doi:10.4314/ahs.v17i3.24
Ahmad, Sargeant, Zaccardi, Khunti, Webb et al., Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?, Pharmaceuticals, doi:10.3390/ph13120427
Alomar, Barakat, Eldosoky, Atef, Mohamed et al., Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity, Int. Immunopharmacol, doi:10.1016/j.intimp.2020.107193
Amin, Khanna, Parvar, Shaw, Dao et al., Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature, Exp. Biol. Med, doi:10.1177/15353702211069986
Amorim, Martins, Fernandes, Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation, Int. J. Mol. Sci, doi:10.3390/ijms24129821
An, He, Current understanding of metformin effect on the control of hyperglycemia in diabetes, J. Endocrinol, doi:10.1530/JOE-15-0447
Bagepally, Chaikledkaew, Gurav, Anothaisintawee, Youngkong et al., Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: Systematic review and meta-analysis of economic evaluation studies, BMJ Open Diabetes Res. Care, doi:10.1136/bmjdrc-2019-001020
Bailey, Metformin: Historical overview, Diabetologia, doi:10.1007/s00125-017-4318-z
Bindu, Mazumder, Bandyopadhyay, Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective, Biochem. Pharmacol, doi:10.1016/j.bcp.2020.114147
Bourget, Adams, Morshead, Reduced microglia activation following metformin administration or microglia ablation is sufficient to prevent functional deficits in a mouse model of neonatal stroke, J. Neuroinflamm, doi:10.1186/s12974-022-02487-x
Bramante, Buse, Liebovitz, Nicklas, Puskarich et al., Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomized, quadruple-blind, parallel-group, phase 3 trial, Lancet Infect. Dis, doi:10.1016/S1473-3099(23)00299-2
Bramante, Ingraham, Murray, Marmor, Hovertsen et al., Metformin and risk of mortality in patients hospitalised with COVID-19: A retrospective cohort analysis, Lancet Healthy Longev, doi:10.1016/S2666-7568(20)30033-7
Buturovic, Ristic, Narancic, Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 Analogues and Metformin in the Treatment of Obese Patients with Poorly Regulated Postprandial Glycemia, Med. Arch, doi:10.5455/medarh.2014.68.313-316
Calixto, Lintomen, André, Leiria, Ferreira et al., Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice, PLoS ONE, doi:10.1371/journal.pone.0076786
Castillo, Peters, Busse, Asthma Exacerbations: Pathogenesis.; Prevention.; and Treatment, J. Allergy Clin. Immunol. Pract, doi:10.1016/j.jaip.2017.05.001
Chellian, Mak, Chellappan, Krishnappa, Pichika, Quercetin and metformin synergistically reverse endothelial dysfunction in the isolated aorta of streptozotocin-nicotinamide-induced diabetic rats, Sci. Rep, doi:10.1038/s41598-022-25739-5
Chen, Chen, Zhang, Fu, Han et al., Elevated CD54 Expression Renders CD4 + T Cells Susceptible to Natural Killer Cell-Mediated Killing, J. Infect. Dis, doi:10.1093/infdis/jiz413
Chen, Yin, Liu, Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway, Ann. Transl. Med, doi:10.21037/atm-21-4764
Cheng, Xu, Wang, Li, Sun et al., Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling, J. Transl. Med, doi:10.1186/s12967-021-03036-5
Chiu, Legrand, Epidemiology of sepsis and septic shock, Curr. Opin. Anaesthesiol, doi:10.1097/ACO.0000000000000958
Coyle, Cafferty, Vale, Langley, Metformin as an adjuvant treatment for cancer: A systematic review and meta-analysis, Ann. Oncol, doi:10.1093/annonc/mdw410
Crouse, Grimes, Li, Might, Ovalle et al., Metformin Use is Associated with Reduced Mortality in a Diverse Population With COVID-19 and Diabetes, Front. Endocrinol, doi:10.3389/fendo.2020.600439
Cui, Zhang, Zhang, Qu, Zheng et al., Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β-catenin and AMPK pathways, J. Cell Mol. Med, doi:10.1111/jcmm.13628
Dandamudi, Slusser, Mahoney, Redfield, Rodeheffer et al., The prevalence of diabetic cardiomyopathy: A population-based study in Olmsted County, Minnesota. J. Card. Fail, doi:10.1016/j.cardfail.2014.02.007
De La Cuesta-Zuluaga, Mueller, Corrales-Agudelo, Velásquez-Mejía, Carmona et al., Metformin is Associated with Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut, Diabetes Care, doi:10.2337/dc16-1324
Detaille, Guigas, Chauvin, Batandier, Fontaine et al., Metformin prevents high-glucoseinduced endothelial cell death through a mitochondrial permeability transition-dependent process, Diabetes, doi:10.2337/diabetes.54.7.2179
Dias, Pinto, Silva, Plant Flavonoids: Chemical Characteristics and Biological Activity, Molecules, doi:10.3390/molecules26175377
Doenyas-Barak, Beberashvili, Marcus, Efrati, Lactic acidosis and severe septic shock in metformin users: A cohort study, Crit. Care, doi:10.1186/s13054-015-1180-6
Domalpally, Whittier, Pan, Dabelea, Darwin et al., Diabetes Prevention Program Research (DPPOS) Group. Association of Metformin with the Development of Age-Related Macular Degeneration, JAMA Ophthalmol, doi:10.1001/jamaophthalmol.2022.5567
Ehteshami-Afshar, Fitzgerald, Doyle-Waters, Sadatsafavi, The global economic burden of asthma and chronic obstructive pulmonary disease, Int. J. Tuberc. Lung Dis, doi:10.5588/ijtld.15.0472
Entezari, Hashemi, Taheriazam, Zabolian, Mohammadi et al., AMPK signaling in diabetes mellitus.; insulin resistance and diabetic complications: A pre-clinical and clinical investigation, Biomed. Pharmacother, doi:10.1016/j.biopha.2021.112563
Espinosa-Rodriguez, Nieto-Moreno, Gonzalez Llerena, Rico-Torres, Carranza-Rosales et al., Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic Approach, Endocr. Metab. Immune Disord.-Drug Targets, doi:10.2174/1871530322666220516115604
Faix, Biomarkers of sepsis, Crit. Rev. Clin. Lab. Sci, doi:10.3109/10408363.2013.764490
Foretz, Guigas, Viollet, Metformin: Update on mechanisms of action and repurposing potential, Nat. Rev. Endocrinol, doi:10.1038/s41574-023-00833-4
Forslund, Hildebrand, Nielsen, Falony, Le Chatelier et al., Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, doi:10.1038/nature15766
Foster, Kellum, Endotoxic Septic Shock: Diagnosis and Treatment, Int. J. Mol. Sci, doi:10.3390/ijms242216185
Froldi, View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences, Pharmaceuticals, doi:10.3390/ph17040478
Glovaci, Fan, Wong, Epidemiology of Diabetes Mellitus and Cardiovascular Disease, Curr. Cardiol. Rep, doi:10.1007/s11886-019-1107-y
Gu, Loube, Lee, Bevans-Fonti, Wu et al., Metformin Alleviates Airway Hyperresponsiveness in a Mouse Model of Diet-Induced Obesity, Front. Physiol, doi:10.3389/fphys.2022.883275
Guo, Shi, Wang, Hong, Chen et al., Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma, J. Cell Mol. Med, doi:10.1111/jcmm.16269
Han, Mallampalli, The acute respiratory distress syndrome: From mechanism to translation, J. Immunol, doi:10.4049/jimmunol.1402513
Han, Wang, Sun, Huang, Wang et al., Metformin Modulates High Glucose-Incubated Human Umbilical Vein Endothelial Cells Proliferation and Apoptosis Through AMPK/CREB/BDNF Pathway, Front. Pharmacol, doi:10.3389/fphar.2018.01266
Hashemi, Pezeshki, Repurposing metformin for COVID-19 complications in patients with type 2 diabetes and insulin resistance, Immunopharmacol. Immunotoxicol, doi:10.1080/08923973.2021.1925294
Heidary, Ebrahimi Samangani, Kargari, Kiani Nejad, Yashmi et al., Mechanism of action, resistance, synergism, and clinical implications of azithromycin, J. Clin. Lab. Anal, doi:10.1002/jcla.24427
Herman, Kravos, Jensterle, Janež, Dolžan, Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport, Int. J. Mol. Sci, doi:10.3390/ijms23031264
Hitchings, Lai, Jones, Baker, Metformin et al., Metformin in severe exacerbations of chronic obstructive pulmonary disease: A randomised controlled trial, Thorax, doi:10.1136/thoraxjnl-2015-208035
Holgate, Wenzel, Postma, Weiss, Renz et al., None, Nat. Rev. Dis. Prim, doi:10.1038/nrdp.2015.25
Hong, Zhang, Lai, Lv, Su et al., Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease, Diabetes Care, doi:10.2337/dc12-0719
Howell, Hellberg, Turner, Talbott, Kolar et al., Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex, Cell Metab, doi:10.1016/j.cmet.2016.12.009
Hsu, Cheng, Mgbeahuruike, Lin, Wu et al., New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway, Int. J. Mol. Sci, doi:10.3390/ijms22179453
Huang, Cai, Su, The Pathogenesis of Sepsis and Potential Therapeutic Targets, Int. J. Mol. Sci, doi:10.3390/ijms20215376
Jenkins, Welsh, Petrie, Metformin, lipids and atherosclerosis prevention, Curr. Opin. Lipidol, doi:10.1097/MOL.0000000000000532
Jian, Alexeyev, Wolkowicz, Zmijewski, Creighton, Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury, Am. J. Physiol. Lung Cell Mol. Physiol, doi:10.1152/ajplung.00173.2013
Jiao, Chen, Xie, Li, Li, Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo, J. Cell Mol. Med, doi:10.1111/jcmm.16677
Kalariya, Shoeb, Ansari, Srivastava, Ramana, Antidiabetic drug metformin suppresses endotoxininduced uveitis in rats, Investig. Ophthalmol. Vis. Sci, doi:10.1167/iovs.12-9432
Kamyshnyi, Matskevych, Lenchuk, Strilbytska, Storey et al., Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential, Biomed. Pharmacother, doi:10.1016/j.biopha.2021.112230
Kim, Lee, Jhun, Byun, Jeong et al., Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21, Mediat. Inflamm, doi:10.1155/2016/5813030
King, Sin, Unravelling the many faces of chronic obstructive pulmonary disease: A hitchhiker's guide to COPD, Respirology, doi:10.1111/resp.12586
Kjøbsted, Kristensen, Birk, Eskesen, Kido et al., Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance, BioRxiv, doi:10.1101/2022.05.22.492936
Klachko, Whaley-Connell, Use of Metformin in Patients with Kidney and Cardiovascular Diseases, Cardiorenal Med, doi:10.1159/000327151
Koh, Kim, Kim, Ko, Kim, Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer, J. Gastroenterol. Hepatol, doi:10.1111/jgh.12435
Konopka, Miller, Taming expectations of metformin as a treatment to extend healthspan, Geroscience, doi:10.1007/s11357-019-00057-3
Kumar, Dey, Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells, Br. J. Pharmacol, doi:10.1038/sj.bjp.0704878
Lamoia, Shulman, Cellular and Molecular Mechanisms of Metformin Action, Endocr. Rev, doi:10.1210/endrev/bnaa023
Li, Erickson, Wu, Metformin use and asthma: Further investigations-Reply, Respirology, doi:10.1111/resp.12922
Li, Gappy, Liu, Sassalos, Zhou et al., Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium, PLoS ONE, doi:10.1371/journal.pone.0268451
Li, Zhao, Guo, Duan, Guo et al., Association of Preadmission Metformin Use and Prognosis in Patients with Sepsis and Diabetes Mellitus: A Systematic Review and Meta-Analysis, Front. Endocrin, doi:10.3389/fendo.2021.811776
Liang, Chen, Tsai, Chang, Chen et al., Association Between Oral Metformin Use and the Development of Age-Related Macular Degeneration in Diabetic Patients: A Systematic Review and Meta-Analysis, Investig. Ophthalmol. Vis. Sci, doi:10.1167/iovs.63.13.10
Liang, Ding, Li, Wang, Kan et al., Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: A systematic review and meta-analysis of cohort studies, Crit. Care, doi:10.1186/s13054-019-2346-4
Liu, Yue, Chen, Chen, Li, Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer, Onco Targets Ther, doi:10.2147/OTT.S242298
Lu, Wu, Shang, Xie, Chen et al., The effects of metformin on autophagy, Biomed. Pharmacother, doi:10.1016/j.biopha.2021.111286
Luo, Qiu, Liu, Liu, Zheng et al., Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis, Am. J. Trop. Med. Hyg, doi:10.4269/ajtmh.20-0375
Ma, Tian, Zhang, Li, Wang et al., Low-dose metformin targets the lysosomal AMPK pathway through PEN2, Nature, doi:10.1038/s41586-022-04431-8
Majithiya, Balaraman, Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocininduced diabetic rats, Life Sci, doi:10.1016/j.lfs.2005.10.020
Manikis, Jankowski, Zhang, Kahn, Vincent, Correlation of serial blood lactate levels to organ failure and mortality after trauma, Am. J. Emerg. Med, doi:10.1016/0735-6757(95)90043-8
Martin-Montalvo, Mercken, Mitchell, Palacios, Mote et al., Metformin improves healthspan and lifespan in mice, Nat. Commun, doi:10.1038/ncomms3192
Masarwa, Brunetti, Aloe, Henderson, Platt et al., Efficacy and Safety of Metformin for Obesity: A Systematic Review, Pediatrics, doi:10.1542/peds.2020-1610
Matsiukevich, Piraino, Lahni, Hake, Wolfe et al., Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock, Biochim. Biophys. Acta (BBA)-Mol. Basis Dis, doi:10.1016/j.bbadis.2017.05.027
Matsumoto, Noguchi, Ishida, Kobayashi, Yamada et al., Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats.; a model of type 2 diabetes, Am. J. Physiol. Heart Circ. Physiol, doi:10.1152/ajpheart.00486.2008
Matsumoto, Sera, Abe, Tominaga, Yeki et al., Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes, Diabetes Res. Clin. Pract, doi:10.1016/j.diabres.2003.11.007
Miller, Birnbaum, An energetic tale of AMPK-independent effects of metformin, J. Clin. Investig, doi:10.1172/JCI43661
Miller, Chu, Xie, Foretz, Viollet et al., Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP, Nature, doi:10.1038/nature11808
Mohammed, Hollenberg, Ding, Triggle, A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan, Front. Endocrinol, doi:10.3389/fendo.2021.718942
Mucha, Skoczy Ńska, Małecka, Hikisz, Budzisz, Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes, Molecules, doi:10.3390/molecules26164886
Nahar, Mohamed, Mustapha, Lau, Ishak et al., Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model, Naunyn-Schmiedeberg's Arch. Pharmacol, doi:10.1007/s00210-020-01989-w
Neha, Haider, Pathak, Yar, Cunningham et al., Medicinal prospects of antioxidants: A review, Eur. J. Med. Chem, doi:10.1097/NOR.0000000000000595
Oh, Song, Association between prior metformin therapy and sepsis in diabetes patients: A nationwide sample cohort study, J. Anesth, doi:10.1007/s00540-020-02753-3
Owen, Doran, Halestrap, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem. J, doi:10.1042/bj3480607
Pan, Han, He, Metformin: One of the possible options to reduce the mortality of severe coronavirus disease 2019? Zhonghua Wei Zhong, Bing Ji Jiu Yi Xue, doi:10.3760/cma.j.cn121430-20200514-00662
Perugini, Di Mercurio, Tossetta, Severi, Monaco et al., Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes, Front. Endocrinol, doi:10.3389/fendo.2019.00768
Piani, Tossetta, Cara-Fuentes, Agnoletti, Marzioni et al., Diagnostic and Prognostic Role of CD93 in Cardiovascular Disease: A Systematic Review, Biomolecules, doi:10.3390/biom13060910
Polverino, Wu, Rojas-Quintero, Wang, Mayo et al., Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.202012-4510OC
Pu, Shi, Gan, Ren, Ba et al., Effects of metformin in obesity treatment in different populations: A meta-analysis, Ther. Adv. Endocrinol. Metab, doi:10.1177/2042018820926000
Pujalte-Martin, Belaïd, Bost, Kahi, Peraldi et al., Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759, Mol. Oncol, doi:10.1002/1878-0261.13583
Rahman, Montero, Rowe, Kirton, Kunik et al., pathogenesis.; clinical presentations.; diagnosis and treatment of COVID-19: A review of current evidence, Expert Rev. Clin. Pharmacol, doi:10.1080/17512433.2021.1902303
Rai, Tiwari, Singh, Singh, Mishra et al., Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease, Oxid. Med. Cell Longev, doi:10.1155/2022/3012778
Regu, Behera, Sunkara, Gohel, Tripathy et al., Ocular Delivery of Metformin for Sustained Release and in Vivo Efficacy, J. Pharm. Sci, doi:10.1016/j.xphs.2023.04.002
Resnick, Howard, Diabetes and cardiovascular disease, Annu. Rev. Med, doi:10.1146/annurev.med.53.082901.103904
Resnick, Shorr, Kuller, Franse, Harris, Prevalence and clinical implications of American Diabetes Associationdefined diabetes and other categories of glucose dysregulation in older adults: The health.; aging and body composition study, J. Clin. Epidemiol, doi:10.1016/s0895-4356(01)00359-6
Restrepo, Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients, Tuberculosis, doi:10.1016/j.tube.2016.09.008
Rhee, Klompas, Sepsis trends: Increasing incidence and decreasing mortality.; or changing denominator?, J. Thorac. Dis, doi:10.21037/jtd.2019.12.51
Rinaldi, Pallikkuth, Cameron, De Armas, Cotugno et al., Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children, J. Immunol, doi:10.4049/jimmunol.1900856
Rizos, Elisaf, Metformin and cancer, Eur. J. Pharmacol, doi:10.1016/j.ejphar.2013.02.038
Romdhoniyyah, Harding, Cheyne, Beare, Metformin, a Potential Role in Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis, Ophthalmol. Ther, doi:10.1007/s40123-021-00344-3
Rothova, Meenken, Michels, Kijlstra, Uveitis and diabetes mellitus, Am. J. Ophthalmol, doi:10.1016/s0002-9394(14)76381-0
Salvi, Brashier, Londhe, Pyasi, Vincent et al., Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease, Respir. Res, doi:10.1186/s12931-020-1310-9
Samuel, Varghese, Büsselberg, Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role, Trends Microbiol, doi:10.1016/j.tim.2021.03.004
Sandquist, Wong, Biomarkers of sepsis and their potential value in diagnosis.; prognosis and treatment, Expert Rev. Clin. Immunol, doi:10.1586/1744666X.2014.949675
Shaito, Aramouni, Assaf, Parenti, Orekhov et al., Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases, Front. Biosci, doi:10.31083/j.fbl2703105
Skei, Nilsen, Mohus, Prescott, Lydersen et al., Trends in mortality after a sepsis hospitalization: A nationwide prospective registry study from 2008 to 2021, Infection, doi:10.1007/s15010-023-02082-z
Soberanes, Misharin, Jairaman, Morales-Nebreda, Mcquattie-Pimentel et al., Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis, Cell Metab, doi:10.1016/j.cmet.2018.09.019
Sobrin, Yu, Han, Susarla, Kempen et al., Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database, Ocul. Immunol. Inflamm, doi:10.1080/09273948.2021.1872650
Song, Bao, Zhang, Zhang, Lv et al., Stimulation of AMPK Prevents Diabetes-Induced Photoreceptor Cell Degeneration, Oxid. Med. Cell Longev, doi:10.1155/2021/5587340
Song, Zhang, Zhai, Liang, Song et al., Metformin attenuated sepsis-associated liver injury and inflammatory response in aged mice, Bioengineered, doi:10.1080/21655979.2022.2036305
Sun, Xie, Wang, Wu, Wu et al., Gut microbiota and intestinal FXR mediate the clinical benefits of metformin, Nat. Med, doi:10.1038/s41591-018-0222-4
Takahara, Takaki, Hiraoka, Takei, Yasutomi et al., Metformin ameliorates chronic colitis in a mouse model by regulating interferon-γ-producing lamina propria CD4 + T cells through AMPK activation, FASEB J, doi:10.1096/fj.202100831RR
Tanner, ACP Journal Club: Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD, Ann. Intern. Med, doi:10.7326/0003-4819-158-8-201304160-02004
Tao, Zhou, Wang, Wang, Zhu et al., Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway, Korean J. Physiol. Pharmacol, doi:10.4196/kjpp.2022.26.2.95
Teng, Brown, Morel, Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus, Antioxid. Redox Signal, doi:10.1089/ars.2021.0070
Tian, Li, Liu, Liu, Pan et al., Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2, Biochim. Biophys. Acta (BBA)-Mol. Basis Dis, doi:10.1016/j.bbadis.2019.04.009
Tseng, Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus, J. Crohn's Colitis, doi:10.1093/ecco-jcc/jjaa136
Tsirouki, Dastiridou, Symeonidis, Tounakaki, Brazitikou et al., A Focus on the Epidemiology of Uveitis, Ocul. Immunol. Inflamm, doi:10.1080/09273948.2016.1196713
Vallianou, Stratigou, Tsagarakis, Metformin and gut microbiota: Their interactions and their impact on diabetes, Hormones, doi:10.1007/s42000-019-00093-w
Velissaris, Bisdorff, Marshall, Vincent, Biomarkers of sepsis: Time for a reappraisal, Crit. Care, doi:10.1186/s13054-020-02993-5
Venu, Saifeddine, Mihara, Faiza, Gorobets et al., Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77), Mol. Pharmacol, doi:10.1124/molpharm.120.000148
Vezza, Víctor, Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients with Sepsis, Crit. Care Med, doi:10.1097/CCM.0000000000005480
Viollet, Guigas, Leclerc, Hébrard, Lantier et al., AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives, Acta Physiol, doi:10.1111/j.1748-1716.2009.01970.x
Volarevic, Misirkic, Vucicevic, Paunovic, Simovic-Markovic et al., Metformin aggravates immune-mediated liver injury in mice, Arch. Toxicol, doi:10.1007/s00204-014-1263-1
Wanchaitanawong, Thinrungroj, Chattipakorn, Chattipakorn, Shinlapawittayatorn, Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic, Int. Immunopharmacol, doi:10.1016/j.intimp.2022.109230
Wang, An, Liu, Qin, Sesaki et al., Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK, Cell Rep, doi:10.1016/j.celrep.2019.09.070
Wang, Wei, Research Progress on the Use of Metformin in Leukemia Treatment, Curr. Treat. Options Oncol, doi:10.1007/s11864-024-01179-3
Wang, Zhang, Torres, Wu, Ouyang et al., Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission, Diabetes, doi:10.2337/db16-0915
Wu, Cen, Feng, Zhou, Tang et al., Metformin Activates the Protective Effects of the AMPK Pathway in Acute Lung Injury Caused by Paraquat Poisoning, Oxid. Med. Cell Longev, doi:10.1155/2019/1709718
Wu, Fawzy, Kinney, Bon, Neupane et al., Metformin use and respiratory outcomes in asthma-COPD overlap, Respir. Res, doi:10.1186/s12931-021-01658-3
Wu, Keet, Fawzy, Segal, Brigham et al., Association of Metformin Initiation and Risk of Asthma Exacerbation. A Claims-based Cohort Study, Ann. Am. Thorac. Soc, doi:10.1513/AnnalsATS.201812-897OC
Xian, Liu, Nilsson, Gatchalian, Crother et al., Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation, Immunity, doi:10.1016/j.immuni.2021.05.004
Zangiabadian, Nejadghaderi, Zahmatkesh, Hajikhani, Mirsaeidi et al., The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review, Front. Endocrinol, doi:10.3389/fendo.2021.645194
Zhao, Lyu, Zhai, Sun, Ding, Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites, Front. Immunol, doi:10.3389/fimmu.2022.797312
Zheng, Chen, Li, Li, Zheng et al., Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin, Diabetes, doi:10.2337/db11-0416
Zhong, Tang, Feng, Peng, Xu et al., Metformin mitigates sepsis-associated pulmonary fibrosis by promoting AMPK activation and inhibiting Hif-1α-induced aerobic glycolysis, Shock, doi:10.1097/SHK.0000000000002275
Ziqubu, Mazibuko-Mbeje, Mthembu, Mabhida, Jack et al., Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target, Int. J. Mol. Sci, doi:10.3390/ijms24032227
{ 'indexed': {'date-parts': [[2024, 5, 11]], 'date-time': '2024-05-11T00:22:26Z', 'timestamp': 1715386946256}, 'reference-count': 142, 'publisher': 'MDPI AG', 'issue': '10', 'license': [ { 'start': { 'date-parts': [[2024, 5, 10]], 'date-time': '2024-05-10T00:00:00Z', 'timestamp': 1715299200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>Metformin, a widely used first-line anti-diabetic therapy for the treatment of type-2 ' 'diabetes, has been shown to lower hyperglycemia levels in the blood by enhancing insulin ' 'actions. For several decades this drug has been used globally to successfully control ' 'hyperglycemia. Lactic acidosis has been shown to be a major adverse effect of metformin in ' 'some type-2 diabetic patients, but several studies suggest that it is a typically ' 'well-tolerated and safe drug in most patients. Further, recent studies also indicate its ' 'potential to reduce the symptoms associated with various inflammatory complications and ' 'infectious diseases including coronavirus disease 2019 (COVID-19). These studies suggest that ' 'besides diabetes, metformin could be used as an adjuvant drug to control inflammatory and ' 'infectious diseases. In this article, we discuss the current understanding of the role of the ' 'anti-diabetic drug metformin in the prevention of various inflammatory complications and ' 'infectious diseases in both diabetics and non-diabetics.</jats:p>', 'DOI': '10.3390/ijms25105190', 'type': 'journal-article', 'created': {'date-parts': [[2024, 5, 10]], 'date-time': '2024-05-10T07:21:04Z', 'timestamp': 1715325664000}, 'page': '5190', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of ' 'Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review', 'prefix': '10.3390', 'volume': '25', 'author': [ { 'given': 'Trevor J.', 'family': 'Plowman', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Noorda College of Osteopathic ' 'Medicine, Provo, UT 84606, USA'}]}, { 'given': 'Hannah', 'family': 'Christensen', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Noorda College of Osteopathic ' 'Medicine, Provo, UT 84606, USA'}]}, { 'given': 'Myia', 'family': 'Aiges', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Noorda College of Osteopathic ' 'Medicine, Provo, UT 84606, USA'}]}, { 'given': 'Emely', 'family': 'Fernandez', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Noorda College of Osteopathic ' 'Medicine, Provo, UT 84606, USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-2442-4874', 'authenticated-orcid': False, 'given': 'Mujtaba H.', 'family': 'Shah', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Noorda College of Osteopathic ' 'Medicine, Provo, UT 84606, USA'}]}, { 'ORCID': 'http://orcid.org/0000-0001-6502-7800', 'authenticated-orcid': False, 'given': 'Kota V.', 'family': 'Ramana', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Noorda College of Osteopathic ' 'Medicine, Provo, UT 84606, USA'}]}], 'member': '1968', 'published-online': {'date-parts': [[2024, 5, 10]]}, 'reference': [ { 'key': 'ref_1', 'doi-asserted-by': 'crossref', 'unstructured': 'Ahmad, E., Sargeant, J.A., Zaccardi, F., Khunti, K., Webb, D.R., and ' 'Davies, M.J. (2020). Where Does Metformin Stand in Modern Day Management ' 'of Type 2 Diabetes?. Pharmaceuticals, 13.', 'DOI': '10.3390/ph13120427'}, { 'key': 'ref_2', 'doi-asserted-by': 'crossref', 'first-page': '1566', 'DOI': '10.1007/s00125-017-4318-z', 'article-title': 'Metformin: Historical overview', 'volume': '60', 'author': 'Bailey', 'year': '2017', 'journal-title': 'Diabetologia'}, { 'key': 'ref_3', 'doi-asserted-by': 'crossref', 'first-page': '77', 'DOI': '10.1210/endrev/bnaa023', 'article-title': 'Cellular and Molecular Mechanisms of Metformin Action', 'volume': '42', 'author': 'LaMoia', 'year': '2021', 'journal-title': 'Endocr. Rev.'}, { 'key': 'ref_4', 'doi-asserted-by': 'crossref', 'first-page': '460', 'DOI': '10.1038/s41574-023-00833-4', 'article-title': 'Metformin: Update on mechanisms of action and repurposing potential', 'volume': '19', 'author': 'Foretz', 'year': '2023', 'journal-title': 'Nat. Rev. Endocrinol.'}, { 'key': 'ref_5', 'doi-asserted-by': 'crossref', 'first-page': 'R97', 'DOI': '10.1530/JOE-15-0447', 'article-title': 'Current understanding of metformin effect on the control of ' 'hyperglycemia in diabetes', 'volume': '228', 'author': 'An', 'year': '2016', 'journal-title': 'J. Endocrinol.'}, { 'key': 'ref_6', 'doi-asserted-by': 'crossref', 'first-page': '159', 'DOI': '10.1038/s41586-022-04431-8', 'article-title': 'Low-dose metformin targets the lysosomal AMPK pathway through PEN2', 'volume': '603', 'author': 'Ma', 'year': '2022', 'journal-title': 'Nature'}, { 'key': 'ref_7', 'doi-asserted-by': 'crossref', 'first-page': '2267', 'DOI': '10.1172/JCI43661', 'article-title': 'An energetic tale of AMPK-independent effects of metformin', 'volume': '120', 'author': 'Miller', 'year': '2010', 'journal-title': 'J. Clin. Investig.'}, { 'key': 'ref_8', 'doi-asserted-by': 'crossref', 'unstructured': 'Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., ' 'Fakhri, F., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., and Zarrabi, ' 'A. (2022). AMPK signaling in diabetes mellitus.; insulin resistance and ' 'diabetic complications: A pre-clinical and clinical investigation. ' 'Biomed. Pharmacother., 146.', 'DOI': '10.1016/j.biopha.2021.112563'}, { 'key': 'ref_9', 'doi-asserted-by': 'crossref', 'first-page': '1511', 'DOI': '10.1016/j.celrep.2019.09.070', 'article-title': 'Metformin Improves Mitochondrial Respiratory Activity through ' 'Activation of AMPK', 'volume': '29', 'author': 'Wang', 'year': '2019', 'journal-title': 'Cell Rep.'}, { 'key': 'ref_10', 'doi-asserted-by': 'crossref', 'first-page': '81', 'DOI': '10.1111/j.1748-1716.2009.01970.x', 'article-title': 'AMP-activated protein kinase in the regulation of hepatic energy ' 'metabolism: From physiology to therapeutic perspectives', 'volume': '196', 'author': 'Viollet', 'year': '2009', 'journal-title': 'Acta Physiol.'}, { 'key': 'ref_11', 'doi-asserted-by': 'crossref', 'first-page': '256', 'DOI': '10.1038/nature11808', 'article-title': 'Biguanides suppress hepatic glucagon signalling by decreasing ' 'production of cyclic AMP', 'volume': '494', 'author': 'Miller', 'year': '2013', 'journal-title': 'Nature'}, { 'key': 'ref_12', 'doi-asserted-by': 'crossref', 'first-page': '462', 'DOI': '10.1089/ars.2021.0070', 'article-title': 'Redox Homeostasis Involvement in the Pharmacological Effects of ' 'Metformin in Systemic Lupus Erythematosus', 'volume': '36', 'author': 'Teng', 'year': '2022', 'journal-title': 'Antioxid. Redox Signal.'}, { 'key': 'ref_13', 'doi-asserted-by': 'crossref', 'unstructured': 'Kjøbsted, R., Kristensen, J.M., Birk, J.B., Eskesen, N.O., Kido, K., ' 'Andersen, N.R., Larsen, J.P., Foretz, M., Viollet, B., and Nielsen, F. ' '(2022). Metformin improves glycemia independently of skeletal muscle ' 'AMPK via enhanced intestinal glucose clearance. BioRxiv, 10.', 'DOI': '10.1101/2022.05.22.492936'}, { 'key': 'ref_14', 'doi-asserted-by': 'crossref', 'unstructured': 'Herman, R., Kravos, N.A., Jensterle, M., Janež, A., and Dolžan, V. ' '(2022). Metformin and Insulin Resistance: A Review of the Underlying ' 'Mechanisms behind Changes in GLUT4-Mediated Glucose Transport. Int. J. ' 'Mol. Sci., 23.', 'DOI': '10.3390/ijms23031264'}, { 'key': 'ref_15', 'doi-asserted-by': 'crossref', 'first-page': '768', 'DOI': '10.3389/fendo.2019.00768', 'article-title': 'Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes', 'volume': '10', 'author': 'Perugini', 'year': '2019', 'journal-title': 'Front. Endocrinol.'}, { 'key': 'ref_16', 'doi-asserted-by': 'crossref', 'first-page': '6733', 'DOI': '10.1111/jcmm.16677', 'article-title': 'Metformin protects against insulin resistance induced by high uric acid ' 'in cardiomyocytes via AMPK signalling pathways in vitro and in vivo', 'volume': '25', 'author': 'Jiao', 'year': '2021', 'journal-title': 'J. Cell Mol. Med.'}, { 'key': 'ref_17', 'doi-asserted-by': 'crossref', 'first-page': '329', 'DOI': '10.1038/sj.bjp.0704878', 'article-title': 'Metformin enhances insulin signalling in insulin-dependent ' 'and-independent pathways in insulin resistant muscle cells', 'volume': '137', 'author': 'Kumar', 'year': '2002', 'journal-title': 'Br. J. Pharmacol.'}, { 'key': 'ref_18', 'doi-asserted-by': 'crossref', 'first-page': 'e001020', 'DOI': '10.1136/bmjdrc-2019-001020', 'article-title': 'Glucagon-like peptide 1 agonists for treatment of patients with type 2 ' 'diabetes who fail metformin monotherapy: Systematic review and ' 'meta-analysis of economic evaluation studies', 'volume': '8', 'author': 'Bagepally', 'year': '2020', 'journal-title': 'BMJ Open Diabetes Res. Care'}, { 'key': 'ref_19', 'doi-asserted-by': 'crossref', 'first-page': '313', 'DOI': '10.5455/medarh.2014.68.313-316', 'article-title': 'Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 ' 'Analogues and Metformin in the Treatment of Obese Patients with Poorly ' 'Regulated Postprandial Glycemia', 'volume': '68', 'author': 'Buturovic', 'year': '2014', 'journal-title': 'Med. Arch.'}, { 'key': 'ref_20', 'doi-asserted-by': 'crossref', 'unstructured': 'Froldi, G. (2024). View on Metformin: Antidiabetic and Pleiotropic ' 'Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. ' 'Pharmaceuticals, 17.', 'DOI': '10.3390/ph17040478'}, { 'key': 'ref_21', 'doi-asserted-by': 'crossref', 'first-page': '11', 'DOI': '10.5588/ijtld.15.0472', 'article-title': 'The global economic burden of asthma and chronic obstructive pulmonary ' 'disease', 'volume': '20', 'author': 'FitzGerald', 'year': '2016', 'journal-title': 'Int. J. Tuberc. Lung Dis.'}, { 'key': 'ref_22', 'doi-asserted-by': 'crossref', 'first-page': '15025', 'DOI': '10.1038/nrdp.2015.25', 'article-title': 'Asthma', 'volume': '1', 'author': 'Holgate', 'year': '2015', 'journal-title': 'Nat. Rev. Dis. Prim.'}, { 'key': 'ref_23', 'doi-asserted-by': 'crossref', 'first-page': '50', 'DOI': '10.1186/s12931-020-1310-9', 'article-title': 'Phenotypic comparison between smoking and non-smoking chronic ' 'obstructive pulmonary disease', 'volume': '21', 'author': 'Salvi', 'year': '2020', 'journal-title': 'Respir. Res.'}, { 'key': 'ref_24', 'doi-asserted-by': 'crossref', 'first-page': '12', 'DOI': '10.1111/resp.12586', 'article-title': 'Unravelling the many faces of chronic obstructive pulmonary disease: A ' 'hitchhiker’s guide to COPD', 'volume': '21', 'author': 'King', 'year': '2016', 'journal-title': 'Respirology'}, { 'key': 'ref_25', 'doi-asserted-by': 'crossref', 'first-page': '918', 'DOI': '10.1016/j.jaip.2017.05.001', 'article-title': 'Asthma Exacerbations: Pathogenesis.; Prevention.; and Treatment', 'volume': '5', 'author': 'Castillo', 'year': '2017', 'journal-title': 'J. Allergy Clin. Immunol. Pract.'}, { 'key': 'ref_26', 'doi-asserted-by': 'crossref', 'first-page': 'e24427', 'DOI': '10.1002/jcla.24427', 'article-title': 'Mechanism of action, resistance, synergism, and clinical implications ' 'of azithromycin', 'volume': '36', 'author': 'Heidary', 'year': '2022', 'journal-title': 'J. Clin. Lab. Anal.'}, { 'key': 'ref_27', 'doi-asserted-by': 'crossref', 'first-page': '3514', 'DOI': '10.1111/jcmm.13628', 'article-title': 'Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with ' 'Wnt3a/β-catenin and AMPK pathways', 'volume': '22', 'author': 'Cui', 'year': '2018', 'journal-title': 'J. Cell Mol. Med.'}, { 'key': 'ref_28', 'doi-asserted-by': 'crossref', 'first-page': '651', 'DOI': '10.1164/rccm.202012-4510OC', 'article-title': 'Metformin: Experimental and Clinical Evidence for a Potential Role in ' 'Emphysema Treatment', 'volume': '204', 'author': 'Polverino', 'year': '2021', 'journal-title': 'Am. J. Respir. Crit. Care Med.'}, { 'key': 'ref_29', 'doi-asserted-by': 'crossref', 'first-page': '883275', 'DOI': '10.3389/fphys.2022.883275', 'article-title': 'Metformin Alleviates Airway Hyperresponsiveness in a Mouse Model of ' 'Diet-Induced Obesity', 'volume': '13', 'author': 'Gu', 'year': '2022', 'journal-title': 'Front. Physiol.'}, { 'key': 'ref_30', 'doi-asserted-by': 'crossref', 'unstructured': 'Calixto, M.C., Lintomen, L., André, D.M., Leiria, L.O., Ferreira, D., ' 'Lellis-Santos, C., Anhê, G.F., Bordin, S., Landgraf, R.G., and Antunes, ' 'E. (2013). Metformin attenuates the exacerbation of the allergic ' 'eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS ' 'ONE, 8.', 'DOI': '10.1371/journal.pone.0076786'}, { 'key': 'ref_31', 'doi-asserted-by': 'crossref', 'first-page': '2279', 'DOI': '10.1111/jcmm.16269', 'article-title': 'Metformin alleviates allergic airway inflammation and increases Treg ' 'cells in obese asthma', 'volume': '25', 'author': 'Guo', 'year': '2021', 'journal-title': 'J. Cell Mol. Med.'}, { 'key': 'ref_32', 'doi-asserted-by': 'crossref', 'first-page': '95', 'DOI': '10.4196/kjpp.2022.26.2.95', 'article-title': 'Metformin alleviates chronic obstructive pulmonary disease and ' 'cigarette smoke extract-induced glucocorticoid resistance by activating ' 'the nuclear factor E2-related factor 2/heme oxygenase-1 signaling ' 'pathway', 'volume': '26', 'author': 'Tao', 'year': '2022', 'journal-title': 'Korean J. Physiol. Pharmacol.'}, { 'key': 'ref_33', 'doi-asserted-by': 'crossref', 'first-page': '203', 'DOI': '10.1111/resp.12922', 'article-title': 'Metformin use and asthma: Further investigations—Reply', 'volume': '22', 'author': 'Li', 'year': '2017', 'journal-title': 'Respirology'}, { 'key': 'ref_34', 'doi-asserted-by': 'crossref', 'first-page': '1527', 'DOI': '10.1513/AnnalsATS.201812-897OC', 'article-title': 'Association of Metformin Initiation and Risk of Asthma Exacerbation. A ' 'Claims-based Cohort Study', 'volume': '16', 'author': 'Wu', 'year': '2019', 'journal-title': 'Ann. Am. Thorac. Soc.'}, { 'key': 'ref_35', 'doi-asserted-by': 'crossref', 'first-page': '587', 'DOI': '10.1136/thoraxjnl-2015-208035', 'article-title': 'Metformin in COPD Trial Team. Metformin in severe exacerbations of ' 'chronic obstructive pulmonary disease: A randomised controlled trial', 'volume': '71', 'author': 'Hitchings', 'year': '2016', 'journal-title': 'Thorax'}, { 'key': 'ref_36', 'doi-asserted-by': 'crossref', 'first-page': '70', 'DOI': '10.1186/s12931-021-01658-3', 'article-title': 'Metformin use and respiratory outcomes in asthma-COPD overlap', 'volume': '22', 'author': 'Wu', 'year': '2021', 'journal-title': 'Respir. Res.'}, { 'key': 'ref_37', 'doi-asserted-by': 'crossref', 'first-page': '1463', 'DOI': '10.1016/j.immuni.2021.05.004', 'article-title': 'Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates ' 'NLRP3 inflammasome activation and pulmonary inflammation', 'volume': '54', 'author': 'Xian', 'year': '2021', 'journal-title': 'Immunity'}, { 'key': 'ref_38', 'doi-asserted-by': 'crossref', 'first-page': '335', 'DOI': '10.1016/j.cmet.2018.09.019', 'article-title': 'Metformin Targets Mitochondrial Electron Transport to Reduce ' 'Air-Pollution-Induced Thrombosis', 'volume': '29', 'author': 'Soberanes', 'year': '2019', 'journal-title': 'Cell Metab.'}, { 'key': 'ref_39', 'doi-asserted-by': 'crossref', 'first-page': '855', 'DOI': '10.4049/jimmunol.1402513', 'article-title': 'The acute respiratory distress syndrome: From mechanism to translation', 'volume': '194', 'author': 'Han', 'year': '2015', 'journal-title': 'J. Immunol.'}, { 'key': 'ref_40', 'doi-asserted-by': 'crossref', 'first-page': '21', 'DOI': '10.1007/s11886-019-1107-y', 'article-title': 'Epidemiology of Diabetes Mellitus and Cardiovascular Disease', 'volume': '21', 'author': 'Glovaci', 'year': '2019', 'journal-title': 'Curr. Cardiol. Rep.'}, { 'key': 'ref_41', 'doi-asserted-by': 'crossref', 'first-page': '245', 'DOI': '10.1146/annurev.med.53.082901.103904', 'article-title': 'Diabetes and cardiovascular disease', 'volume': '53', 'author': 'Resnick', 'year': '2002', 'journal-title': 'Annu. Rev. Med.'}, { 'key': 'ref_42', 'doi-asserted-by': 'crossref', 'first-page': '304', 'DOI': '10.1016/j.cardfail.2014.02.007', 'article-title': 'The prevalence of diabetic cardiomyopathy: A population-based study in ' 'Olmsted County.; Minnesota', 'volume': '20', 'author': 'Dandamudi', 'year': '2014', 'journal-title': 'J. Card. Fail.'}, { 'key': 'ref_43', 'doi-asserted-by': 'crossref', 'first-page': '869', 'DOI': '10.1016/S0895-4356(01)00359-6', 'article-title': 'Prevalence and clinical implications of American Diabetes ' 'Association-defined diabetes and other categories of glucose ' 'dysregulation in older adults: The health.; aging and body composition ' 'study', 'volume': '54', 'author': 'Resnick', 'year': '2001', 'journal-title': 'J. Clin. Epidemiol.'}, { 'key': 'ref_44', 'doi-asserted-by': 'crossref', 'first-page': '346', 'DOI': '10.1097/MOL.0000000000000532', 'article-title': 'Metformin, lipids and atherosclerosis prevention', 'volume': '29', 'author': 'Jenkins', 'year': '2018', 'journal-title': 'Curr. Opin. Lipidol.'}, { 'key': 'ref_45', 'doi-asserted-by': 'crossref', 'first-page': '87', 'DOI': '10.1159/000327151', 'article-title': 'Use of Metformin in Patients with Kidney and Cardiovascular Diseases', 'volume': '1', 'author': 'Klachko', 'year': '2011', 'journal-title': 'Cardiorenal Med.'}, { 'key': 'ref_46', 'doi-asserted-by': 'crossref', 'unstructured': 'Shaito, A., Aramouni, K., Assaf, R., Parenti, A., Orekhov, A., Yazbi, ' 'A.E., Pintus, G., and Eid, A.H. (2022). Oxidative Stress-Induced ' 'Endothelial Dysfunction in Cardiovascular Diseases. Front. Biosci., 27.', 'DOI': '10.31083/j.fbl2703105'}, { 'key': 'ref_47', 'doi-asserted-by': 'crossref', 'unstructured': 'Piani, F., Tossetta, G., Cara-Fuentes, G., Agnoletti, D., Marzioni, D., ' 'and Borghi, C. (2023). Diagnostic and Prognostic Role of CD93 in ' 'Cardiovascular Disease: A Systematic Review. Biomolecules, 13.', 'DOI': '10.3390/biom13060910'}, { 'key': 'ref_48', 'doi-asserted-by': 'crossref', 'first-page': '1266', 'DOI': '10.3389/fphar.2018.01266', 'article-title': 'Metformin Modulates High Glucose-Incubated Human Umbilical Vein ' 'Endothelial Cells Proliferation and Apoptosis Through AMPK/CREB/BDNF ' 'Pathway', 'volume': '9', 'author': 'Han', 'year': '2018', 'journal-title': 'Front. Pharmacol.'}, { 'key': 'ref_49', 'doi-asserted-by': 'crossref', 'first-page': '1547', 'DOI': '10.21037/atm-21-4764', 'article-title': 'Metformin alleviates bevacizumab-induced vascular endothelial injury by ' 'up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling ' 'pathway', 'volume': '9', 'author': 'Chen', 'year': '2021', 'journal-title': 'Ann. Transl. Med.'}, { 'key': 'ref_50', 'doi-asserted-by': 'crossref', 'first-page': '2179', 'DOI': '10.2337/diabetes.54.7.2179', 'article-title': 'Metformin prevents high-glucose-induced endothelial cell death through ' 'a mitochondrial permeability transition-dependent process', 'volume': '54', 'author': 'Detaille', 'year': '2005', 'journal-title': 'Diabetes'}, { 'key': 'ref_51', 'doi-asserted-by': 'crossref', 'first-page': '428', 'DOI': '10.1124/molpharm.120.000148', 'article-title': 'Metformin Prevents Hyperglycemia-Associated.; Oxidative Stress-Induced ' 'Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear ' 'Receptor Human Nuclear Receptor 4A1 (Nur77)', 'volume': '100', 'author': 'Venu', 'year': '2021', 'journal-title': 'Mol. Pharmacol.'}, { 'key': 'ref_52', 'doi-asserted-by': 'crossref', 'first-page': '21393', 'DOI': '10.1038/s41598-022-25739-5', 'article-title': 'Quercetin and metformin synergistically reverse endothelial dysfunction ' 'in the isolated aorta of streptozotocin-nicotinamide- induced diabetic ' 'rats', 'volume': '12', 'author': 'Chellian', 'year': '2022', 'journal-title': 'Sci. Rep.'}, { 'key': 'ref_53', 'doi-asserted-by': 'crossref', 'first-page': 'H1165', 'DOI': '10.1152/ajpheart.00486.2008', 'article-title': 'Metformin normalizes endothelial function by suppressing ' 'vasoconstrictor prostanoids in mesenteric arteries from OLETF rats.; a ' 'model of type 2 diabetes', 'volume': '295', 'author': 'Matsumoto', 'year': '2008', 'journal-title': 'Am. J. Physiol. Heart Circ. Physiol.'}, { 'key': 'ref_54', 'doi-asserted-by': 'crossref', 'first-page': '2615', 'DOI': '10.1016/j.lfs.2005.10.020', 'article-title': 'Metformin reduces blood pressure and restores endothelial function in ' 'aorta of streptozotocin-induced diabetic rats', 'volume': '78', 'author': 'Majithiya', 'year': '2006', 'journal-title': 'Life Sci.'}, { 'key': 'ref_55', 'doi-asserted-by': 'crossref', 'first-page': '193', 'DOI': '10.2337/db16-0915', 'article-title': 'Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the ' 'Inhibition of Drp1-Mediated Mitochondrial Fission', 'volume': '66', 'author': 'Wang', 'year': '2017', 'journal-title': 'Diabetes'}, { 'key': 'ref_56', 'doi-asserted-by': 'crossref', 'first-page': '1304', 'DOI': '10.2337/dc12-0719', 'article-title': 'Effects of metformin versus glipizide on cardiovascular outcomes in ' 'patients with type 2 diabetes and coronary artery disease', 'volume': '36', 'author': 'Hong', 'year': '2013', 'journal-title': 'Diabetes Care'}, { 'key': 'ref_57', 'doi-asserted-by': 'crossref', 'first-page': 'JC4', 'DOI': '10.7326/0003-4819-158-8-201304160-02004', 'article-title': 'ACP Journal Club: Metformin reduced CV events compared with glipizide ' 'in patients with type 2 diabetes and CAD', 'volume': '158', 'author': 'Tanner', 'year': '2013', 'journal-title': 'Ann. Intern. Med.'}, { 'key': 'ref_58', 'doi-asserted-by': 'crossref', 'first-page': '225', 'DOI': '10.1016/j.diabres.2003.11.007', 'article-title': 'Metformin attenuates progression of carotid arterial wall thickness in ' 'patients with type 2 diabetes', 'volume': '64', 'author': 'Matsumoto', 'year': '2004', 'journal-title': 'Diabetes Res. Clin. Pract.'}, { 'key': 'ref_59', 'doi-asserted-by': 'crossref', 'unstructured': 'Amorim, M., Martins, B., and Fernandes, R. (2023). Immune Fingerprint in ' 'Diabetes: Ocular Surface and Retinal Inflammation. Int. J. Mol. Sci., ' '24.', 'DOI': '10.20944/preprints202305.0932.v1'}, { 'key': 'ref_60', 'doi-asserted-by': 'crossref', 'first-page': '17', 'DOI': '10.1016/S0002-9394(14)76381-0', 'article-title': 'Uveitis and diabetes mellitus', 'volume': '106', 'author': 'Rothova', 'year': '1988', 'journal-title': 'Am. J. Ophthalmol.'}, { 'key': 'ref_61', 'doi-asserted-by': 'crossref', 'first-page': '107193', 'DOI': '10.1016/j.intimp.2020.107193', 'article-title': 'Protective effect of metformin on rat diabetic retinopathy involves ' 'suppression of toll-like receptor 4/nuclear factor-k B expression and ' 'glutamate excitotoxicity', 'volume': '90', 'author': 'Alomar', 'year': '2021', 'journal-title': 'Int. Immunopharmacol.'}, { 'key': 'ref_62', 'doi-asserted-by': 'crossref', 'first-page': '217', 'DOI': '10.2337/db11-0416', 'article-title': 'Sirtuin 1-mediated cellular metabolic memory of high glucose via the ' 'LKB1/AMPK/ROS pathway and therapeutic effects of metformin', 'volume': '61', 'author': 'Zheng', 'year': '2012', 'journal-title': 'Diabetes'}, { 'key': 'ref_63', 'doi-asserted-by': 'crossref', 'first-page': '245', 'DOI': '10.1007/s40123-021-00344-3', 'article-title': 'Metformin, a Potential Role in Age-Related Macular Degeneration: A ' 'Systematic Review and Meta-Analysis', 'volume': '10', 'author': 'Romdhoniyyah', 'year': '2021', 'journal-title': 'Ophthalmol. Ther.'}, { 'key': 'ref_64', 'doi-asserted-by': 'crossref', 'first-page': '140', 'DOI': '10.1001/jamaophthalmol.2022.5567', 'article-title': 'Diabetes Prevention Program Research (DPPOS) Group. Association of ' 'Metformin with the Development of Age-Related Macular Degeneration', 'volume': '141', 'author': 'Domalpally', 'year': '2023', 'journal-title': 'JAMA Ophthalmol.'}, { 'key': 'ref_65', 'doi-asserted-by': 'crossref', 'unstructured': 'Hsu, S.K., Cheng, K.C., Mgbeahuruike, M.O., Lin, Y.H., Wu, C.Y., Wang, ' 'H.D., Yen, C.H., Chiu, C.C., and Sheu, S.J. (2021). New Insight into the ' 'Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: ' 'Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK ' 'Pathway. Int. J. Mol. Sci., 22.', 'DOI': '10.3390/ijms22179453'}, { 'key': 'ref_66', 'doi-asserted-by': 'crossref', 'first-page': '2', 'DOI': '10.1080/09273948.2016.1196713', 'article-title': 'A Focus on the Epidemiology of Uveitis', 'volume': '26', 'author': 'Tsirouki', 'year': '2018', 'journal-title': 'Ocul. Immunol. Inflamm.'}, { 'key': 'ref_67', 'doi-asserted-by': 'crossref', 'first-page': '3431', 'DOI': '10.1167/iovs.12-9432', 'article-title': 'Antidiabetic drug metformin suppresses endotoxin-induced uveitis in ' 'rats', 'volume': '53', 'author': 'Kalariya', 'year': '2012', 'journal-title': 'Investig. Ophthalmol. Vis. Sci.'}, { 'key': 'ref_68', 'doi-asserted-by': 'crossref', 'unstructured': 'Li, Y., Gappy, S., Liu, X., Sassalos, T., Zhou, T., Hsu, A., Zhang, A., ' 'Edwards, P.A., Gao, H., and Qiao, X. (2022). Metformin suppresses ' 'pro-inflammatory cytokines in vitreous of diabetes patients and human ' 'retinal vascular endothelium. PLoS ONE, 17.', 'DOI': '10.1371/journal.pone.0268451'}, { 'key': 'ref_69', 'doi-asserted-by': 'crossref', 'first-page': '5587340', 'DOI': '10.1155/2021/5587340', 'article-title': 'Stimulation of AMPK Prevents Diabetes-Induced Photoreceptor Cell ' 'Degeneration', 'volume': '2021', 'author': 'Song', 'year': '2021', 'journal-title': 'Oxid. Med. Cell Longev.'}, { 'key': 'ref_70', 'doi-asserted-by': 'crossref', 'first-page': '457', 'DOI': '10.1007/s00210-020-01989-w', 'article-title': 'Metformin attenuated histopathological ocular deteriorations in a ' 'streptozotocin-induced hyperglycemic rat model', 'volume': '394', 'author': 'Nahar', 'year': '2021', 'journal-title': 'Naunyn-Schmiedeberg’s Arch. Pharmacol.'}, { 'key': 'ref_71', 'doi-asserted-by': 'crossref', 'first-page': '2494', 'DOI': '10.1016/j.xphs.2023.04.002', 'article-title': 'Ocular Delivery of Metformin for Sustained Release and in Vivo Efficacy', 'volume': '112', 'author': 'Regu', 'year': '2023', 'journal-title': 'J. Pharm. Sci.'}, { 'key': 'ref_72', 'doi-asserted-by': 'crossref', 'first-page': '317', 'DOI': '10.1177/15353702211069986', 'article-title': 'Metformin and retinal diseases in preclinical and clinical studies: ' 'Insights and review of literature', 'volume': '247', 'author': 'Amin', 'year': '2022', 'journal-title': 'Exp. Biol. Med.'}, { 'key': 'ref_73', 'doi-asserted-by': 'crossref', 'first-page': '1334', 'DOI': '10.1080/09273948.2021.1872650', 'article-title': 'Risk of Non-infectious Uveitis with Metformin Therapy in a Large ' 'Healthcare Claims Database', 'volume': '30', 'author': 'Sobrin', 'year': '2022', 'journal-title': 'Ocul. Immunol. Inflamm.'}, { 'key': 'ref_74', 'doi-asserted-by': 'crossref', 'first-page': '10', 'DOI': '10.1167/iovs.63.13.10', 'article-title': 'Association Between Oral Metformin Use and the Development of ' 'Age-Related Macular Degeneration in Diabetic Patients: A Systematic ' 'Review and Meta-Analysis', 'volume': '63', 'author': 'Liang', 'year': '2022', 'journal-title': 'Investig. Ophthalmol. Vis. Sci.'}, { 'key': 'ref_75', 'doi-asserted-by': 'crossref', 'unstructured': 'Foster, D.M., and Kellum, J.A. (2023). Endotoxic Septic Shock: Diagnosis ' 'and Treatment. Int. J. Mol. Sci., 24.', 'DOI': '10.3390/ijms242216185'}, { 'key': 'ref_76', 'doi-asserted-by': 'crossref', 'first-page': '71', 'DOI': '10.1097/ACO.0000000000000958', 'article-title': 'Epidemiology of sepsis and septic shock', 'volume': '34', 'author': 'Chiu', 'year': '2021', 'journal-title': 'Curr. Opin. Anaesthesiol.'}, { 'key': 'ref_77', 'doi-asserted-by': 'crossref', 'first-page': 'S89', 'DOI': '10.21037/jtd.2019.12.51', 'article-title': 'Sepsis trends: Increasing incidence and decreasing mortality.; or ' 'changing denominator?', 'volume': '12', 'author': 'Rhee', 'year': '2020', 'journal-title': 'J. Thorac. Dis.'}, { 'key': 'ref_78', 'doi-asserted-by': 'crossref', 'first-page': '1773', 'DOI': '10.1007/s15010-023-02082-z', 'article-title': 'Trends in mortality after a sepsis hospitalization: A nationwide ' 'prospective registry study from 2008 to 2021', 'volume': '51', 'author': 'Skei', 'year': '2023', 'journal-title': 'Infection'}, { 'key': 'ref_79', 'doi-asserted-by': 'crossref', 'first-page': '287', 'DOI': '10.1186/s13054-020-02993-5', 'article-title': 'Biomarkers of sepsis: Time for a reappraisal', 'volume': '24', 'author': 'Velissaris', 'year': '2020', 'journal-title': 'Crit. Care'}, { 'key': 'ref_80', 'doi-asserted-by': 'crossref', 'first-page': '1349', 'DOI': '10.1586/1744666X.2014.949675', 'article-title': 'Biomarkers of sepsis and their potential value in diagnosis.; prognosis ' 'and treatment', 'volume': '10', 'author': 'Sandquist', 'year': '2014', 'journal-title': 'Expert Rev. Clin. Immunol.'}, { 'key': 'ref_81', 'doi-asserted-by': 'crossref', 'first-page': '619', 'DOI': '10.1016/0735-6757(95)90043-8', 'article-title': 'Correlation of serial blood lactate levels to organ failure and ' 'mortality after trauma', 'volume': '13', 'author': 'Manikis', 'year': '1995', 'journal-title': 'Am. J. Emerg. Med.'}, { 'key': 'ref_82', 'doi-asserted-by': 'crossref', 'unstructured': 'Huang, M., Cai, S., and Su, J. (2019). The Pathogenesis of Sepsis and ' 'Potential Therapeutic Targets. Int. J. Mol. Sci., 20.', 'DOI': '10.3390/ijms20215376'}, { 'key': 'ref_83', 'doi-asserted-by': 'crossref', 'first-page': '23', 'DOI': '10.3109/10408363.2013.764490', 'article-title': 'Biomarkers of sepsis', 'volume': '50', 'author': 'Faix', 'year': '2013', 'journal-title': 'Crit. Rev. Clin. Lab. Sci.'}, { 'key': 'ref_84', 'doi-asserted-by': 'crossref', 'first-page': '1701', 'DOI': '10.1016/j.bbadis.2019.04.009', 'article-title': 'Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory ' 'responses via AMPK-dependent mediation of HDAC5 and KLF2', 'volume': '1865', 'author': 'Tian', 'year': '2019', 'journal-title': 'Biochim. Biophys. Acta (BBA)-Mol. Basis Dis.'}, { 'key': 'ref_85', 'doi-asserted-by': 'crossref', 'first-page': '4598', 'DOI': '10.1080/21655979.2022.2036305', 'article-title': 'Metformin attenuated sepsis-associated liver injury and inflammatory ' 'response in aged mice', 'volume': '13', 'author': 'Song', 'year': '2022', 'journal-title': 'Bioengineered'}, { 'key': 'ref_86', 'doi-asserted-by': 'crossref', 'first-page': '2680', 'DOI': '10.1016/j.bbadis.2017.05.027', 'article-title': 'Metformin ameliorates gender-and age-dependent hemodynamic instability ' 'and myocardial injury in murine hemorrhagic shock', 'volume': '1863', 'author': 'Matsiukevich', 'year': '2017', 'journal-title': 'Biochim. Biophys. Acta (BBA)-Mol. Basis Dis.'}, { 'key': 'ref_87', 'doi-asserted-by': 'crossref', 'first-page': '797312', 'DOI': '10.3389/fimmu.2022.797312', 'article-title': 'Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut ' 'Microbiota and Metabolites', 'volume': '13', 'author': 'Zhao', 'year': '2022', 'journal-title': 'Front. Immunol.'}, { 'key': 'ref_88', 'doi-asserted-by': 'crossref', 'first-page': '2192', 'DOI': '10.1038/ncomms3192', 'article-title': 'Metformin improves healthspan and lifespan in mice', 'volume': '4', 'author': 'Mercken', 'year': '2013', 'journal-title': 'Nat. Commun.'}, { 'key': 'ref_89', 'doi-asserted-by': 'crossref', 'first-page': '718942', 'DOI': '10.3389/fendo.2021.718942', 'article-title': 'A Critical Review of the Evidence That Metformin Is a Putative ' 'Anti-Aging Drug That Enhances Healthspan and Extends Lifespan', 'volume': '12', 'author': 'Mohammed', 'year': '2021', 'journal-title': 'Front. Endocrinol.'}, { 'key': 'ref_90', 'doi-asserted-by': 'crossref', 'first-page': '101', 'DOI': '10.1007/s11357-019-00057-3', 'article-title': 'Taming expectations of metformin as a treatment to extend healthspan', 'volume': '41', 'author': 'Konopka', 'year': '2019', 'journal-title': 'Geroscience'}, { 'key': 'ref_91', 'doi-asserted-by': 'crossref', 'first-page': '146', 'DOI': '10.1186/s12974-022-02487-x', 'article-title': 'Reduced microglia activation following metformin administration or ' 'microglia ablation is sufficient to prevent functional deficits in a ' 'mouse model of neonatal stroke', 'volume': '19', 'author': 'Bourget', 'year': '2022', 'journal-title': 'J. Neuroinflamm.'}, { 'key': 'ref_92', 'doi-asserted-by': 'crossref', 'first-page': 'L844', 'DOI': '10.1152/ajplung.00173.2013', 'article-title': 'Metformin-stimulated AMPK-α1 promotes microvascular repair in acute ' 'lung injury', 'volume': '305', 'author': 'Jian', 'year': '2013', 'journal-title': 'Am. J. Physiol. Lung Cell Mol. Physiol.'}, { 'key': 'ref_93', 'doi-asserted-by': 'crossref', 'first-page': '1709718', 'DOI': '10.1155/2019/1709718', 'article-title': 'Metformin Activates the Protective Effects of the AMPK Pathway in Acute ' 'Lung Injury Caused by Paraquat Poisoning', 'volume': '2019', 'author': 'Wu', 'year': '2019', 'journal-title': 'Oxid. Med. Cell Longev.'}, { 'key': 'ref_94', 'doi-asserted-by': 'crossref', 'first-page': '811776', 'DOI': '10.3389/fendo.2021.811776', 'article-title': 'Association of Preadmission Metformin Use and Prognosis in Patients ' 'with Sepsis and Diabetes Mellitus: A Systematic Review and ' 'Meta-Analysis', 'volume': '12', 'author': 'Li', 'year': '2021', 'journal-title': 'Front. Endocrin.'}, { 'key': 'ref_95', 'doi-asserted-by': 'crossref', 'first-page': '10', 'DOI': '10.1186/s13054-015-1180-6', 'article-title': 'Lactic acidosis and severe septic shock in metformin users: A cohort ' 'study', 'volume': '20', 'author': 'Beberashvili', 'year': '2016', 'journal-title': 'Crit. Care'}, { 'key': 'ref_96', 'doi-asserted-by': 'crossref', 'first-page': '358', 'DOI': '10.1007/s00540-020-02753-3', 'article-title': 'Association between prior metformin therapy and sepsis in diabetes ' 'patients: A nationwide sample cohort study', 'volume': '34', 'author': 'Oh', 'year': '2020', 'journal-title': 'J. Anesth.'}, { 'key': 'ref_97', 'doi-asserted-by': 'crossref', 'first-page': '50', 'DOI': '10.1186/s13054-019-2346-4', 'article-title': 'Association of preadmission metformin use and mortality in patients ' 'with sepsis and diabetes mellitus: A systematic review and ' 'meta-analysis of cohort studies', 'volume': '23', 'author': 'Liang', 'year': '2019', 'journal-title': 'Crit. Care'}, { 'key': 'ref_98', 'doi-asserted-by': 'crossref', 'first-page': '1018', 'DOI': '10.1097/CCM.0000000000005480', 'article-title': 'Metformin: An Intriguing Protective Agent in Hospitalized Diabetic ' 'Patients with Sepsis', 'volume': '50', 'author': 'Vezza', 'year': '2022', 'journal-title': 'Crit. Care Med.'}, { 'key': 'ref_99', 'doi-asserted-by': 'crossref', 'first-page': '601', 'DOI': '10.1080/17512433.2021.1902303', 'article-title': 'Epidemiology.; pathogenesis.; clinical presentations.; diagnosis and ' 'treatment of COVID-19: A review of current evidence', 'volume': '14', 'author': 'Rahman', 'year': '2021', 'journal-title': 'Expert Rev. Clin. Pharmacol.'}, { 'key': 'ref_100', 'doi-asserted-by': 'crossref', 'unstructured': 'Dias, M.C., Pinto, D.C.G.A., and Silva, A.M.S. (2021). Plant Flavonoids: ' 'Chemical Characteristics and Biological Activity. Molecules, 26.', 'DOI': '10.3390/molecules26175377'}, { 'key': 'ref_101', 'doi-asserted-by': 'crossref', 'unstructured': 'Mucha, P., Skoczyńska, A., Małecka, M., Hikisz, P., and Budzisz, E. ' '(2021). Overview of the Antioxidant and Anti-Inflammatory Activities of ' 'Selected Plant Compounds and Their Metal Ions Complexes. Molecules, 26.', 'DOI': '10.3390/molecules26164886'}, { 'key': 'ref_102', 'doi-asserted-by': 'crossref', 'first-page': '687', 'DOI': '10.1016/j.ejmech.2019.06.010', 'article-title': 'Medicinal prospects of antioxidants: A review', 'volume': '178', 'author': 'Neha', 'year': '2019', 'journal-title': 'Eur. J. Med. Chem.'}, { 'key': 'ref_103', 'doi-asserted-by': 'crossref', 'first-page': '336', 'DOI': '10.1097/NOR.0000000000000595', 'article-title': 'Corticosteroids', 'volume': '8', 'author': 'Kapugi', 'year': '2019', 'journal-title': 'Orthop. Nurs.'}, { 'key': 'ref_104', 'doi-asserted-by': 'crossref', 'unstructured': 'Bindu, S., Mazumder, S., and Bandyopadhyay, U. (2020). Non-steroidal ' 'anti-inflammatory drugs (NSAIDs) and organ damage: A current ' 'perspective. Biochem. Pharmacol., 180.', 'DOI': '10.1016/j.bcp.2020.114147'}, { 'key': 'ref_105', 'doi-asserted-by': 'crossref', 'first-page': '1892', 'DOI': '10.1093/infdis/jiz413', 'article-title': 'Elevated CD54 Expression Renders CD4+ T Cells Susceptible to Natural ' 'Killer Cell-Mediated Killing', 'volume': '220', 'author': 'Chen', 'year': '2019', 'journal-title': 'J. Infect. Dis.'}, { 'key': 'ref_106', 'doi-asserted-by': 'crossref', 'first-page': '437', 'DOI': '10.1007/s00204-014-1263-1', 'article-title': 'Metformin aggravates immune-mediated liver injury in mice', 'volume': '89', 'author': 'Volarevic', 'year': '2015', 'journal-title': 'Arch. Toxicol.'}, { 'key': 'ref_107', 'doi-asserted-by': 'crossref', 'first-page': '808', 'DOI': '10.4314/ahs.v17i3.24', 'article-title': 'Repurposing metformin as a quorum sensing inhibitor in Pseudomonas ' 'aeruginosa', 'volume': '17', 'author': 'Abbas', 'year': '2017', 'journal-title': 'Afr. Health Sci.'}, { 'key': 'ref_108', 'doi-asserted-by': 'crossref', 'first-page': '607', 'DOI': '10.1042/bj3480607', 'article-title': 'Evidence that metformin exerts its anti-diabetic effects through ' 'inhibition of complex 1 of the mitochondrial respiratory chain', 'volume': '348', 'author': 'Owen', 'year': '2000', 'journal-title': 'Biochem. J.'}, { 'key': 'ref_109', 'doi-asserted-by': 'crossref', 'first-page': '540', 'DOI': '10.4049/jimmunol.1900856', 'article-title': 'Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 ' 'and CD8 T Cell Function in Perinatally Infected Children', 'volume': '204', 'author': 'Rinaldi', 'year': '2020', 'journal-title': 'J. Immunol.'}, { 'key': 'ref_110', 'doi-asserted-by': 'crossref', 'first-page': 'S69', 'DOI': '10.1016/j.tube.2016.09.008', 'article-title': 'Metformin: Candidate host-directed therapy for tuberculosis in diabetes ' 'and non-diabetes patients', 'volume': '101', 'author': 'Restrepo', 'year': '2016', 'journal-title': 'Tuberculosis'}, { 'key': 'ref_111', 'doi-asserted-by': 'crossref', 'first-page': 'e22139', 'DOI': '10.1096/fj.202100831RR', 'article-title': 'Metformin ameliorates chronic colitis in a mouse model by regulating ' 'interferon-γ-producing lamina propria CD4+ T cells through AMPK ' 'activation', 'volume': '36', 'author': 'Takahara', 'year': '2022', 'journal-title': 'FASEB J.'}, { 'key': 'ref_112', 'doi-asserted-by': 'crossref', 'first-page': '502', 'DOI': '10.1111/jgh.12435', 'article-title': 'Anti-inflammatory mechanism of metformin and its effects in intestinal ' 'inflammation and colitis-associated colon cancer', 'volume': '29', 'author': 'Koh', 'year': '2014', 'journal-title': 'J. Gastroenterol. Hepatol.'}, { 'key': 'ref_113', 'doi-asserted-by': 'crossref', 'first-page': '109230', 'DOI': '10.1016/j.intimp.2022.109230', 'article-title': 'Repurposing metformin as a potential treatment for inflammatory bowel ' 'disease: Evidence from cell to the clinic', 'volume': '112', 'author': 'Wanchaitanawong', 'year': '2022', 'journal-title': 'Int. Immunopharmacol.'}, { 'key': 'ref_114', 'doi-asserted-by': 'crossref', 'first-page': '64', 'DOI': '10.1093/ecco-jcc/jjaa136', 'article-title': 'Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel ' 'Disease in Patients with Type 2 Diabetes Mellitus', 'volume': '15', 'author': 'Tseng', 'year': '2021', 'journal-title': 'J. Crohn’s Colitis'}, { 'key': 'ref_115', 'doi-asserted-by': 'crossref', 'first-page': '1919', 'DOI': '10.1038/s41591-018-0222-4', 'article-title': 'Gut microbiota and intestinal FXR mediate the clinical benefits of ' 'metformin', 'volume': '24', 'author': 'Sun', 'year': '2018', 'journal-title': 'Nat. Med.'}, { 'key': 'ref_116', 'doi-asserted-by': 'crossref', 'first-page': '141', 'DOI': '10.1007/s42000-019-00093-w', 'article-title': 'Metformin and gut microbiota: Their interactions and their impact on ' 'diabetes', 'volume': '18', 'author': 'Vallianou', 'year': '2019', 'journal-title': 'Hormones'}, { 'key': 'ref_117', 'doi-asserted-by': 'crossref', 'first-page': '262', 'DOI': '10.1038/nature15766', 'article-title': 'Disentangling type 2 diabetes and metformin treatment signatures in the ' 'human gut microbiota', 'volume': '528', 'author': 'Forslund', 'year': '2015', 'journal-title': 'Nature'}, { 'key': 'ref_118', 'doi-asserted-by': 'crossref', 'first-page': '54', 'DOI': '10.2337/dc16-1324', 'article-title': 'Metformin is Associated with Higher Relative Abundance of ' 'Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty ' 'Acid-Producing Microbiota in the Gut', 'volume': '40', 'author': 'Mueller', 'year': '2017', 'journal-title': 'Diabetes Care'}, { 'key': 'ref_119', 'doi-asserted-by': 'crossref', 'first-page': '600439', 'DOI': '10.3389/fendo.2020.600439', 'article-title': 'Metformin Use is Associated with Reduced Mortality in a Diverse ' 'Population With COVID-19 and Diabetes', 'volume': '11', 'author': 'Crouse', 'year': '2021', 'journal-title': 'Front. Endocrinol.'}, { 'key': 'ref_120', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.4269/ajtmh.20-0375', 'article-title': 'Metformin Treatment Was Associated with Decreased Mortality in COVID-19 ' 'Patients with Diabetes in a Retrospective Analysis', 'volume': '103', 'author': 'Luo', 'year': '2020', 'journal-title': 'Am. J. Trop. Med. Hyg.'}, { 'key': 'ref_121', 'doi-asserted-by': 'crossref', 'first-page': 'e34', 'DOI': '10.1016/S2666-7568(20)30033-7', 'article-title': 'Metformin and risk of mortality in patients hospitalised with COVID-19: ' 'A retrospective cohort analysis', 'volume': '2', 'author': 'Bramante', 'year': '2021', 'journal-title': 'Lancet Healthy Longev.'}, { 'key': 'ref_122', 'doi-asserted-by': 'crossref', 'first-page': '1119', 'DOI': '10.1016/S1473-3099(23)00299-2', 'article-title': 'Outpatient treatment of COVID-19 and incidence of post-COVID-19 ' 'condition over 10 months (COVID-OUT): A multicentre, randomized, ' 'quadruple-blind, parallel-group, phase 3 trial', 'volume': '23', 'author': 'Bramante', 'year': '2023', 'journal-title': 'Lancet Infect. Dis.'}, { 'key': 'ref_123', 'doi-asserted-by': 'crossref', 'first-page': '265', 'DOI': '10.1080/08923973.2021.1925294', 'article-title': 'Repurposing metformin for COVID-19 complications in patients with type ' '2 diabetes and insulin resistance', 'volume': '43', 'author': 'Hashemi', 'year': '2021', 'journal-title': 'Immunopharmacol. Immunotoxicol.'}, { 'key': 'ref_124', 'doi-asserted-by': 'crossref', 'first-page': '283', 'DOI': '10.1097/SHK.0000000000002275', 'article-title': 'Metformin mitigates sepsis-associated pulmonary fibrosis by promoting ' 'AMPK activation and inhibiting Hif-1α-induced aerobic glycolysis', 'volume': '61', 'author': 'Zhong', 'year': '2023', 'journal-title': 'Shock'}, { 'key': 'ref_125', 'doi-asserted-by': 'crossref', 'first-page': '349', 'DOI': '10.1186/s12967-021-03036-5', 'article-title': 'Metformin attenuates silica-induced pulmonary fibrosis via AMPK ' 'signaling', 'volume': '19', 'author': 'Cheng', 'year': '2021', 'journal-title': 'J. Transl. Med.'}, { 'key': 'ref_126', 'first-page': '1131', 'article-title': 'Metformin: One of the possible options to reduce the mortality of ' 'severe coronavirus disease 2019?', 'volume': '32', 'author': 'Pan', 'year': '2020', 'journal-title': 'Zhonghua Wei Zhong Bing Ji Jiu Yi Xue'}, { 'key': 'ref_127', 'doi-asserted-by': 'crossref', 'first-page': '255', 'DOI': '10.2174/1871530322666220516115604', 'article-title': 'Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic ' 'Approach', 'volume': '23', 'year': '2023', 'journal-title': 'Endocr. Metab. Immune Disord.-Drug Targets'}, { 'key': 'ref_128', 'doi-asserted-by': 'crossref', 'first-page': '3012778', 'DOI': '10.1155/2022/3012778', 'article-title': 'Exploring the Paradox of COVID-19 in Neurological Complications with ' 'Emphasis on Parkinson’s and Alzheimer’s Disease', 'volume': '2022', 'author': 'Rai', 'year': '2022', 'journal-title': 'Oxid. Med. Cell Longev.'}, { 'key': 'ref_129', 'doi-asserted-by': 'crossref', 'unstructured': 'Kamyshnyi, O., Matskevych, V., Lenchuk, T., Strilbytska, O., Storey, K., ' 'and Lushchak, O. (2021). Metformin to decrease COVID-19 severity and ' 'mortality: Molecular mechanisms and therapeutic potential. Biomed. ' 'Pharmacother., 144.', 'DOI': '10.1016/j.biopha.2021.112230'}, { 'key': 'ref_130', 'doi-asserted-by': 'crossref', 'first-page': '894', 'DOI': '10.1016/j.tim.2021.03.004', 'article-title': 'Therapeutic Potential of Metformin in COVID-19: Reasoning for Its ' 'Protective Role', 'volume': '29', 'author': 'Samuel', 'year': '2021', 'journal-title': 'Trends Microbiol.'}, { 'key': 'ref_131', 'doi-asserted-by': 'crossref', 'first-page': '645194', 'DOI': '10.3389/fendo.2021.645194', 'article-title': 'The Efficacy and Potential Mechanisms of Metformin in the Treatment of ' 'COVID-19 in the Diabetics: A Systematic Review', 'volume': '12', 'author': 'Zangiabadian', 'year': '2021', 'journal-title': 'Front. Endocrinol.'}, { 'key': 'ref_132', 'doi-asserted-by': 'crossref', 'first-page': '2042018820926000', 'DOI': '10.1177/2042018820926000', 'article-title': 'Effects of metformin in obesity treatment in different populations: A ' 'meta-analysis', 'volume': '11', 'author': 'Pu', 'year': '2020', 'journal-title': 'Ther. Adv. Endocrinol. Metab.'}, { 'key': 'ref_133', 'doi-asserted-by': 'crossref', 'first-page': 'e20201610', 'DOI': '10.1542/peds.2020-1610', 'article-title': 'Efficacy and Safety of Metformin for Obesity: A Systematic Review', 'volume': '147', 'author': 'Masarwa', 'year': '2020', 'journal-title': 'Pediatrics'}, { 'key': 'ref_134', 'doi-asserted-by': 'crossref', 'first-page': '5813030', 'DOI': '10.1155/2016/5813030', 'article-title': 'Metformin Prevents Fatty Liver and Improves Balance of White/Brown ' 'Adipose in an Obesity Mouse Model by Inducing FGF21', 'volume': '2016', 'author': 'Kim', 'year': '2016', 'journal-title': 'Mediat. Inflamm.'}, { 'key': 'ref_135', 'doi-asserted-by': 'crossref', 'unstructured': 'Ziqubu, K., Mazibuko-Mbeje, S.E., Mthembu, S.X.H., Mabhida, S.E., Jack, ' 'B.U., Nyambuya, T.M., Nkambule, B.B., Basson, A.K., Tiano, L., and ' 'Dludla, P.V. (2023). Anti-Obesity Effects of Metformin: A Scoping Review ' 'Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic ' 'Target. Int. J. Mol. Sci., 24.', 'DOI': '10.3390/ijms24032227'}, { 'key': 'ref_136', 'doi-asserted-by': 'crossref', 'first-page': '220', 'DOI': '10.1007/s11864-024-01179-3', 'article-title': 'Research Progress on the Use of Metformin in Leukemia Treatment', 'volume': '25', 'author': 'Wang', 'year': '2024', 'journal-title': 'Curr. Treat. Options Oncol.'}, { 'key': 'ref_137', 'doi-asserted-by': 'crossref', 'unstructured': 'Pujalte-Martin, M., Belaïd, A., Bost, S., Kahi, M., Peraldi, P., ' 'Rouleau, M., Mazure, N.M., and Bost, F. (2024). Targeting cancer and ' 'immune cell metabolism with the complex I inhibitors metformin and ' 'IACS-010759. Mol. Oncol.', 'DOI': '10.1002/1878-0261.13583'}, { 'key': 'ref_138', 'doi-asserted-by': 'crossref', 'first-page': '2184', 'DOI': '10.1093/annonc/mdw410', 'article-title': 'Metformin as an adjuvant treatment for cancer: A systematic review and ' 'meta-analysis', 'volume': '12', 'author': 'Coyle', 'year': '2016', 'journal-title': 'Ann. Oncol.'}, { 'key': 'ref_139', 'doi-asserted-by': 'crossref', 'first-page': '96', 'DOI': '10.1016/j.ejphar.2013.02.038', 'article-title': 'Metformin and cancer', 'volume': '705', 'author': 'Rizos', 'year': '2013', 'journal-title': 'Eur. J. Pharmacol.'}, { 'key': 'ref_140', 'doi-asserted-by': 'crossref', 'unstructured': 'Lu, G., Wu, Z., Shang, J., Xie, Z., Chen, C., and Zhang, C. (2021). The ' 'effects of metformin on autophagy. Biomed. Pharmacother., 137.', 'DOI': '10.1016/j.biopha.2021.111286'}, { 'key': 'ref_141', 'doi-asserted-by': 'crossref', 'first-page': '463', 'DOI': '10.1016/j.cmet.2016.12.009', 'article-title': 'Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent ' 'Mechanisms Involving AMPK and the TSC Complex', 'volume': '25', 'author': 'Howell', 'year': '2017', 'journal-title': 'Cell Metab.'}, { 'key': 'ref_142', 'doi-asserted-by': 'crossref', 'first-page': '4445', 'DOI': '10.2147/OTT.S242298', 'article-title': 'Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the ' 'Progression of Gastric Cancer', 'volume': '13', 'author': 'Liu', 'year': '2020', 'journal-title': 'Onco Targets Ther.'}], 'container-title': 'International Journal of Molecular Sciences', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.mdpi.com/1422-0067/25/10/5190/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 5, 10]], 'date-time': '2024-05-10T07:43:02Z', 'timestamp': 1715326982000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.mdpi.com/1422-0067/25/10/5190'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 5, 10]]}, 'references-count': 142, 'journal-issue': {'issue': '10', 'published-online': {'date-parts': [[2024, 5]]}}, 'alternative-id': ['ijms25105190'], 'URL': 'http://dx.doi.org/10.3390/ijms25105190', 'relation': {}, 'ISSN': ['1422-0067'], 'subject': [], 'container-title-short': 'IJMS', 'published': {'date-parts': [[2024, 5, 10]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit